NCT02553447View on ClinicalTrials.gov

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

NAActive, not recruitingINTERVENTIONAL

Enrollment

197

Participants

Timeline

Start Date

October 19, 2015

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Chronic Lymphocytic LeukemiaNon-Hodgkin LymphomaUntreated Chronic Lymphocytic LeukemiaVitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

Cholecalciferol

Given PO

OTHER

Laboratory Biomarker Analysis

Optional correlative studies

Trial Locations (1)

68198

University of Nebraska Medical Center, Omaha

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Nebraska

OTHER

NCT02553447 - Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency | Biotech Hunter | Biotech Hunter